Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06176781
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-20
First Post:
2023-12-11
Brief Title:
The Efficacy and Safety of Edaravone Dexborneol Sequential Therapy in the Treatment of Patients With AIS
Sponsor:
Simcere Pharmaceutical Co Ltd
Organization:
Simcere Pharmaceutical Co Ltd
Organization Data
Organization:
Simcere Pharmaceutical Co Ltd
Class:
OTHER
Study ID:
SIM0308-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Simcere Pharmaceutical Co Ltd
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None